The consequences of President Trump's actions on drug pricing continue to play out, with Bristol Myers Squibb insisting it will charge the same in the UK for new schizophrenia drug Cobenfy as in the ...

What’s old is new again. Crossbodies with flaps, one of the most staid and practical silhouettes on the market, popped up over and over again on the fall runways, including at Khaite, Burberry, and ...

We speak to Thomas Bodé, chief digital transformation officer at European energy company Met Group, about delivering successful digital initiatives.

Lenders are continuing to nudge up the cost of fixed rate deals as market uncertainty grows over the direction of interest rates, writes Jo Thornhill. Experts believe higher than expected inflation ...

Lenders continue to tweak fixed rate pricing both upwards and downwards, as the outlook for interest rates is uncertain but competition within specific sectors of the market remains fierce, writes Jo ...